Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...

Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...

Companies are leaning into new U.S. factories, while capital is starting to look elsewhere, Ludovic Subran writes in a guest ...

A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...

Corporate America is scrambling to implement countermeasures as U.S. President Donald Trump's latest tariffs on Chinese ...

Public officials and the media blamed high egg prices on bird flu outbreaks and said containing the outbreak in supply chains ...

Korean automaker Hyundai is the latest to announce plans to boost investment in the U.S. to ramp up domestic manufacturing.

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants. A number of companies have highlighted ...

Johnson & Johnson Chairman and CEO Joaquin Duato says “our increased U.S. investment begins with the ground-breaking of a ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.